Abstract
To reduce the risks of immunization with killed or live attenuated virus vaccines, it may be advantageous to use a pure, defined antigen that contains determinants for both humoral and cellular immunity. However, although most non-living intact protein pre-parations induce antibodies and CD4+major histocompatibility complex (MHC) class Il-restricted helper and/or cytotoxic T lymphocytes (CTL), they do not elicit CD8+ MHC class I restricted CTL1,2. Indeed, with a few exceptions3,4 it has not so far been possible to induce CD8+ CTL by immunizing with intact soluble proteins. We show here that a single subcutaneous immunization in mice with immunostimulating complexes containing either purified intact gploO envelope glycoprotein of the human immunodeficiency virus (HIV)-l or influenza haemagglutinin results in reproducible and long-lasting priming of HIV specific or influenza-specific CD8+, MHC class I restricted CTL.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Morrison, L. A., Lukacher, A. E., Braciale, V. L., Fan, D. P. & Braciale, T. J. J. exp. Med. 163, 903–921 (1986).
Germain, R. N. Nature 322, 687–689 (1986).
Staerz, U. D., Karasuyama, H. & Garner, A. M. Nature 329, 449–451 (1987).
Wraith, D. C. & Askonas, B. A. J. gen. Virol. 66, 1327–1331 (1985).
Morein, B., Sundquist, B., Höglund, S., Dalsgaard, K. & Osterhaus, A. Nature 308, 457–460 (1984).
Takahashi, H. et al. Proc. natn. Acad. Sci. U.S.A. 85, 3105–3109 (1988).
Cease, K. B. et al. Proc. natn. Acad. Sci. U.S.A. 84, 4249–4253 (1987).
Jones, P. D., Tha Hla, R., Morein, B., Lövgren, K. & Ada, G. L. Scand. J. Immun. 27, 645–652 (1988).
Townsend, A. R. M. et al. Cell 44, 959–968 (1986).
Maryanski, J. L., Pala, P., Corradin, G., Jordan, B. R. & Cerottini, J.-C. Nature 324, 578–579 (1986).
Moore, M. W., Carbone, F. R. & Bevan, M. J. Cell 54, 777–785 (1988).
Ishioka, G. Y., Colon, S., Miles, C., Grey, H. M. & Chesnut, R. W. J. Immun. 143, 1094–1100 (1989).
Takahashi, H. et al. Science 246, 118–121 (1989).
Takahashi, H. et al. J. exp. Med. 170, 2023–2035 (1989).
Achour, A. et al. Vth Int. Conf. on AIDS, Montreal 546 abstract, (1989).
Hildreth, J. E. K. Biochem. J. 207, 363–366 (1982).
Javaherian, K. et al. Proc. natn. Acad. Sci. U.S.A. 86, 6768–6772 (1989).
Sarmiento, M., Glasebrook, A. L. & Fitch, F. W. J. Immun. 125, 2665–2672 (1980).
Ceredig, R., Lowenthal, J. W., Nabholz, M. & MacDonald, H. R. Nature 314, 98–100 (1985).
Margulies, D. H. et al. J. Immun. 130, 463 (1983).
Abastado, J.-P. et al. J. exp. Med. 166, 327–340 (1987).
Bennink, J. R. & Yewdell, J. W. J. exp. Med. 168, 1935–1939 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Takahashi, H., Takeshfta, T., Morein, B. et al. Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature 344, 873–875 (1990). https://doi.org/10.1038/344873a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/344873a0
This article is cited by
-
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Journal of Nanobiotechnology (2024)
-
Induction of tumor-specific CD8+ cytotoxic T lymphocytes from naïve human T cells by using Mycobacterium-derived mycolic acid and lipoarabinomannan-stimulated dendritic cells
Cancer Immunology, Immunotherapy (2019)
-
A CD4-mimetic compound enhances vaccine efficacy against stringent immunodeficiency virus challenge
Nature Communications (2018)
-
Inactivation of tumor‐specific CD8+ CTLs by tumor‐infiltrating tolerogenic dendritic cells
Immunology & Cell Biology (2013)
-
Antitumor effects of Newcastle disease virus hemagglutinin-neuraminidase used as a molecular adjuvant
Chemical Research in Chinese Universities (2013)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.